BRPI0716084A2 - mÉtodo de avaliaÇço da ativaÇço de cÉlulas b associada a artrite; mÉtodo de avaliaÇço de um paciente quanto a uma indicaÇço de uma resposta autoimune; mÉtodo de tratamento de cÉlulas b; mÉtodo de tratamento de artrite reumatàide em um paciente; mÉtodo de avaliaÇço de um tratamento para cÉlulas b; anticorpo purificado ou monoclonal; e mÉtodo de busca de uma cÉlula ativada. - Google Patents

mÉtodo de avaliaÇço da ativaÇço de cÉlulas b associada a artrite; mÉtodo de avaliaÇço de um paciente quanto a uma indicaÇço de uma resposta autoimune; mÉtodo de tratamento de cÉlulas b; mÉtodo de tratamento de artrite reumatàide em um paciente; mÉtodo de avaliaÇço de um tratamento para cÉlulas b; anticorpo purificado ou monoclonal; e mÉtodo de busca de uma cÉlula ativada.

Info

Publication number
BRPI0716084A2
BRPI0716084A2 BRPI0716084-4A2A BRPI0716084A BRPI0716084A2 BR PI0716084 A2 BRPI0716084 A2 BR PI0716084A2 BR PI0716084 A BRPI0716084 A BR PI0716084A BR PI0716084 A2 BRPI0716084 A2 BR PI0716084A2
Authority
BR
Brazil
Prior art keywords
patient
evaluating
cell
treatment
arthritis
Prior art date
Application number
BRPI0716084-4A2A
Other languages
English (en)
Inventor
David Von Schack
Matthew Whitters
Kyriaki Dunussi-Joannopoulos
Mary Collins
Eugene Brown
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0716084A2 publication Critical patent/BRPI0716084A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
BRPI0716084-4A2A 2006-08-25 2007-08-22 mÉtodo de avaliaÇço da ativaÇço de cÉlulas b associada a artrite; mÉtodo de avaliaÇço de um paciente quanto a uma indicaÇço de uma resposta autoimune; mÉtodo de tratamento de cÉlulas b; mÉtodo de tratamento de artrite reumatàide em um paciente; mÉtodo de avaliaÇço de um tratamento para cÉlulas b; anticorpo purificado ou monoclonal; e mÉtodo de busca de uma cÉlula ativada. BRPI0716084A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84038006P 2006-08-25 2006-08-25
PCT/US2007/018540 WO2008027256A2 (en) 2006-08-25 2007-08-22 Arthritis-associated b cell gene expression

Publications (1)

Publication Number Publication Date
BRPI0716084A2 true BRPI0716084A2 (pt) 2013-10-01

Family

ID=39136481

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716084-4A2A BRPI0716084A2 (pt) 2006-08-25 2007-08-22 mÉtodo de avaliaÇço da ativaÇço de cÉlulas b associada a artrite; mÉtodo de avaliaÇço de um paciente quanto a uma indicaÇço de uma resposta autoimune; mÉtodo de tratamento de cÉlulas b; mÉtodo de tratamento de artrite reumatàide em um paciente; mÉtodo de avaliaÇço de um tratamento para cÉlulas b; anticorpo purificado ou monoclonal; e mÉtodo de busca de uma cÉlula ativada.

Country Status (10)

Country Link
US (1) US20090022731A1 (pt)
EP (1) EP2054528A2 (pt)
JP (1) JP2010501182A (pt)
CN (1) CN101535503A (pt)
AU (1) AU2007290667A1 (pt)
BR (1) BRPI0716084A2 (pt)
CA (1) CA2661744A1 (pt)
MX (1) MX2009002015A (pt)
TW (1) TW200817035A (pt)
WO (1) WO2008027256A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000079B (zh) * 2010-09-30 2012-05-30 中国人民解放军第二军医大学 尼克酰胺单核苷酸磷酸核糖转移酶抑制剂的应用
CN102346190A (zh) * 2011-01-24 2012-02-08 中国人民解放军第三军医大学 用于检测生物标本中的过氧化物还原酶ⅳ的双抗夹心elisa试剂盒及其方法与运用
GB201103062D0 (en) * 2011-02-22 2011-04-06 Isis Innovation Method
EP2934586A4 (en) * 2012-12-21 2016-05-25 Univ California TSPAN 33 AS A CANDIDATE FOR ANTIBODY-TREATED THERAPY FOR THE TREATMENT OF B-CELL HODGKIN LYMPHOMES
JP2014221065A (ja) * 2014-07-07 2014-11-27 ユニヴァーシタ デグリ ステューディ ディ パドヴァ ２つの遺伝子の発現の観察による乳癌患者の予後診断
EP3957994A1 (en) * 2014-11-07 2022-02-23 Fujikura Kasei Co., Ltd. Digestive system cancer detection method using deoxyhypusine synthase gene as indicator
CN106244675B (zh) * 2016-06-20 2020-01-14 石金龙 成人aml危险度分层和临床预后评估试剂盒及cpne3的应用
WO2018056825A1 (en) * 2016-09-23 2018-03-29 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Manipulation of immune activity by modulation of expression
JP6816876B2 (ja) * 2016-11-11 2021-01-20 国立大学法人富山大学 Ｒｏ５２／ＴＲＩＭ２１タンパク質に対する自己抗体が認識するエピトープおよびその利用
US20200149042A1 (en) * 2017-07-14 2020-05-14 William N. Haining Modulating biomarkers to increase tumor immunity and improve the efficacy of cancer immunotherapy
CN107789615B (zh) * 2017-10-23 2021-01-05 王宇泽 DAla2GIP在治疗骨性关节炎中的用途
US10773710B2 (en) 2018-05-09 2020-09-15 Ford Global Technologies, Llc Systems and methods for a hybrid vehicle with a manual shift transmission

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002230997A1 (en) * 2000-12-15 2002-06-24 Genetics Institute, Llc Methods and compositions for diagnosing and treating rheumatoid arthritis
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
AUPR974101A0 (en) * 2001-12-24 2002-01-24 Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland, The Novel polynucleotides and uses therefor
ES2555994T3 (es) * 2004-05-21 2016-01-12 The Board Of Trustees Of The University Of Arkansas System Uso de perfiles de expresión génica para predecir la supervivencia en un paciente con cáncer

Also Published As

Publication number Publication date
WO2008027256A3 (en) 2008-11-20
JP2010501182A (ja) 2010-01-21
TW200817035A (en) 2008-04-16
US20090022731A1 (en) 2009-01-22
AU2007290667A1 (en) 2008-03-06
MX2009002015A (es) 2009-03-05
WO2008027256A2 (en) 2008-03-06
EP2054528A2 (en) 2009-05-06
CA2661744A1 (en) 2008-03-06
CN101535503A (zh) 2009-09-16

Similar Documents

Publication Publication Date Title
BRPI0716084A2 (pt) mÉtodo de avaliaÇço da ativaÇço de cÉlulas b associada a artrite; mÉtodo de avaliaÇço de um paciente quanto a uma indicaÇço de uma resposta autoimune; mÉtodo de tratamento de cÉlulas b; mÉtodo de tratamento de artrite reumatàide em um paciente; mÉtodo de avaliaÇço de um tratamento para cÉlulas b; anticorpo purificado ou monoclonal; e mÉtodo de busca de uma cÉlula ativada.
DK2119452T3 (da) Farmaceutisk sammensætning, omfattende et anti-cd6-monoklonal antistof anvendt ved diagnosticering og be-handling af rheumatoid arthritis
DK2007282T3 (da) Fremgangsmåde til diagnosticering af ADHD og beslægtede adfærdsforstyrrelser
NO20043583L (no) Analytisk innretning med predikteringsmodul og relaterte metoder
DE602004032000D1 (de) Festpolymerelektrolyt-Brennstoffzellensystem und Betriebsverfahren dafür
MX344935B (es) Analisis para detectar anticuerpos especificos a anticuerpos anti-ige terapeuticos y su uso en anafilaxis.
DE112005001818T5 (de) Gasleckerfassungsvorrichtung und Brennstoffzellensystem
WO2012118750A3 (en) Biological markers and methods for predicting response to b-cell antagonists
DK1910642T3 (da) Apparat og fremgangsmåde til overvågning af affaldsgeninjektionsslam
DE112007000808B8 (de) Brennstoffzellensystem und Ventilöffnungsgrad-Berechnungsverfahren für das Brennstoffzellensystem
DE602005019961D1 (de) Steuervorrichtung und Verfahren zu deren Herstellung
DK2190984T3 (da) Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG
BRPI0916624A2 (pt) anticorpos monoclonais seletivos anti-hepcidina-25, seus usos, bem como método e kit para quantificar a quantidade de proteína hepcidina-25 em uma amostra de tecido ou fluido biológico
DE602006011934D1 (de) Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern
DE602007002413D1 (de) Brennstoffreformierungssystem und Brennstoffzellensystem damit
GB0414623D0 (en) Method and system for determining the focus of a document
ATE504002T1 (de) Erkennung und vorhersage von frühgeburten
DOP2006000155A (es) Diagnóstico de artritis reumatoide por imágenes ópticas
EP1717329A4 (en) FERRITSCHER STAINLESS STEEL FOR FESTPOLYMER FUEL CELL SAVOR AND FESTPOLYMER FUEL CELL
ITRM20030386A0 (it) Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
DE602005021815D1 (de) Brennstoffzellenstarterverfahren und brennstoffzellensystem
DE602005002241D1 (de) Brennstoffzellensystem und verfahren zu seiner steuerung
AU2003234549A8 (en) Systems and methods for identifying organ transplant risk
DE602005027637D1 (de) Stapelmodul für Medienausgabegerät und Verfahren zu dessen Steuerung
ITFI20060310A1 (it) Dispositivo portatile per la misura ed il controllo di analiti in fluidi biologici.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired